Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial
IL-15 and its receptor might be a promising target for vitiligo treatment (129)
In reality, things are often a little more complicated
In mouse models, it was found that L-theanine could improve the anticonvulsive effect of pentobarbital sodium in a dose-dependent manner (52)
Risk factors that might warrant consideration of medication adjustment include: Recent initiation or dose escalation of GLP-1 therapy Significant gastrointestinal symptoms (nausea, vomiting, early satiety) Maximum medication doses Known gastroparesis or other conditions affecting gastric emptying For patients where holding the medication is deemed appropriate, the duration should be individualized based on the specific medication, patient factors, and clinical judgment
What Is Binge Eating Disorder